Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site: a phase 2 trial of the Sarah Cannon Oncology Research Consortium.

Details

Language :

English

ISSN :

0008543X

Volume :

116

Issue :

10

Database :

Complementary Index

Journal :

Cancer (0008543X)

Publication Type :

Academic Journal

Accession number :

105192244

Full Text :

https://doi.org/10.1002/cncr.25029